Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.

Berinstein, Neil L; McNamara, Michael; Nguyen, Ariane; Egan, James; Wolf, Gregory T

Berinstein, Neil L; McNamara, Michael; Nguyen, Ariane; Egan, James; Wolf, Gregory T.

Afiliación

Berinstein NL; Sunnybrook Health Science Center, Toronto, Ontario, Canada.
McNamara M; Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA.
Nguyen A; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Egan J; IRX Therapeutics, New York, New York, USA.
Wolf GT; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.

Oncoimmunology ; 7(5): e1423173, 2018.

Article en En | MEDLINE | ID: mdl-29721379

Palabras clave

Cytokines; T cells; dendritic cells; head and neck squamous cell carcinoma; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article País de afiliación: Canadá